Ensign Peak Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85,392
| Closed | -$378K | – | 1705 |
|
|
2024
Q4 | $378K | Hold |
85,392
| – | – | ﹤0.01% | 1655 |
|
|
2024
Q3 | $352K | Hold |
85,392
| – | – | ﹤0.01% | 1665 |
|
|
2024
Q2 | $557K | Hold |
85,392
| – | – | ﹤0.01% | 1576 |
|
|
2024
Q1 | $744K | Sell |
85,392
-4,308
| -5% | -$37.5K | ﹤0.01% | 1499 |
|
|
2023
Q4 | $1.03M | Hold |
89,700
| – | – | ﹤0.01% | 1357 |
|
|
2023
Q3 | $864K | Buy |
89,700
+500
| +0.6% | +$4.82K | ﹤0.01% | 1312 |
|
|
2023
Q2 | $949K | Hold |
89,200
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q1 | $938K | Hold |
89,200
| – | – | ﹤0.01% | 1291 |
|
|
2022
Q4 | $1.11M | Buy |
89,200
+63,950
| +253% | +$792K | ﹤0.01% | 1083 |
|
|
2022
Q3 | $262K | Buy |
+25,250
| New | +$262K | ﹤0.01% | 1767 |
|